Cargando…
Efficacy and safety of rivaroxaban for the treatment of PICC-related upper extremity deep vein thrombosis in cancer patients: a retrospective study
BACKGROUND: The optimal duration and choice of anticoagulant for the treatment of Peripherally inserted central catheters (PICC)-related upper extremity deep vein thrombosis (UEDVT) in cancer patients are still undetermined. OBJECTIVES: The aim of this study was to assess the efficacy and safety of...
Autores principales: | Xu, Jiaxuan, Wang, Guodong, Chen, Xiaojie, Shen, Yanfen, Wang, Xinpeng, Wang, Hongzhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890768/ https://www.ncbi.nlm.nih.gov/pubmed/36726149 http://dx.doi.org/10.1186/s12959-023-00456-9 |
Ejemplares similares
-
Upper extremity deep vein thrombosis after migration of peripherally inserted central catheter (PICC): A case report
por: Wang, Kai, et al.
Publicado: (2017) -
The anticoagulants rivaroxaban and low molecular weight heparin prevent PICC-related upper extremity venous thrombosis in cancer patients
por: Lv, Shoutian, et al.
Publicado: (2019) -
Upper extremity deep vein thrombosis
por: Saseedharan, Sanjith, et al.
Publicado: (2012) -
Predictive Value of Red Cell Distribution Width in the Diagnosis of Peripherally Inserted Central Catheter (PICC)-Related Thrombosis Among Cancer Patients
por: Zhai, Rui, et al.
Publicado: (2023) -
Systemic thrombolysis in the upper extremity deep vein thrombosis
por: Sadeghi, Roxana, et al.
Publicado: (2011)